MSI Financial Services’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$0 Hold
2
﹤0.01% 4225
2016
Q3
$0 Sell
2
-13
-87% -$47 ﹤0.01% 4260
2016
Q2
$0 Hold
15
﹤0.01% 4309
2016
Q1
$0 Hold
15
﹤0.01% 4307
2015
Q4
$0 Hold
15
﹤0.01% 4151
2015
Q3
$0 Buy
15
+13
+650% +$225 ﹤0.01% 3587
2015
Q2
$0 Hold
2
﹤0.01% 3447
2015
Q1
$0 Hold
2
﹤0.01% 3290
2014
Q4
$0 Hold
2
﹤0.01% 2945
2014
Q3
$0 Hold
2
﹤0.01% 2871
2014
Q2
$0 Hold
2
﹤0.01% 2760
2014
Q1
$0 Hold
2
﹤0.01% 2757
2013
Q4
$0 Sell
2
-1
-33% -$18 ﹤0.01% 2729
2013
Q3
$0 Buy
3
+1
+50% +$12 ﹤0.01% 2613
2013
Q2
$0 Buy
+2
New +$23 ﹤0.01% 2482

Other funds holding CTIC

MSI Financial Services's CTIC Position: Q4 2016 in Review

MSI Financial Services held its CTI BioPharma Corp. (DE) Common Stock (CTIC) position steady in Q4 2016 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4225.

MSI Financial Services first reported a position in CTIC in Q2 2013 and has held it in 15 quarters since. 58 funds tracked by Wall St. Rank hold CTIC as of Q4 2016.

  • MSI Financial Services held 2 shares of CTI BioPharma Corp. (DE) Common Stock worth $0 as of Q4 2016.
  • MSI Financial Services left its CTI BioPharma Corp. (DE) Common Stock share count unchanged in Q4 2016.
  • CTI BioPharma Corp. (DE) Common Stock made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #4225 holding.
  • MSI Financial Services first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and has held it in 15 quarters since.
  • 58 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.